Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis
FDA Office of Acquisition Grant Services
This contract includes 1 purchase order from Sep 16, 2025 to Sep 16, 2025
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| FDA Office of Acquisition Grant Services | WE Pharma, Inc. | Sep 16, 2025 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
FDA Office of Acquisition Grant Services
TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR).
Effective Date
Jul 28, 2025
Expires
FDA Office of Acquisition Grant Services
Expires:
TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR).
ActiveFDA Office of Acquisition Grant Services
PHARMACEUTICAL DRUG PRODUCTS
Effective Date
May 14, 2025
Expires
Effective: May 14, 2025
FDA Office of Acquisition Grant Services
Expires:
PHARMACEUTICAL DRUG PRODUCTS
ActiveFDA Office of Acquisition Grant Services
TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS UNDER IDIQ CONTRACT 75F40124D00020.
Effective Date
Jul 2, 2024
Expires
FDA Office of Acquisition Grant Services
Expires:
TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS UNDER IDIQ CONTRACT 75F40124D00020.
ActiveFDA Office of Acquisition Grant Services
IMF-DESTRUCTION OF FDA REGULATED PRODUCTS SERVICES
Effective Date
Jan 1, 2023
Expires
Effective: Jan 1, 2023
FDA Office of Acquisition Grant Services
Expires:
IMF-DESTRUCTION OF FDA REGULATED PRODUCTS SERVICES
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis